Travis Bernardo

  • Travis Bernardo

    2013 - PhD Molecular Biology, Fordham University

    2007 - MS Molecular Biology, Fordham University

    2006 - BS Biology, Fordham University

    Academic Background

    As a doctoral student at Fordham University, Dr Bernardo studied the hormonal regulation of transcription in the model organism Drosophila melanogaster. His postdoctoral research at Albert Einstein College of Medicine focused on epigenetic control of development and chromatin compaction in Drosophila. From 2013 to 2016, he concurrently served as an adjunct professor teaching biology, biotechnology, and ecology courses at Iona College and Fordham University.

    Publishing History

    Dr Bernardo has published (as author and co-author) seven peer-reviewed journal articles, and is author of a book chapter on juvenile hormone signaling. He has also published medical news features for Albert Einstein College of Medicine, and science news articles for the American Society for Cell Biology COMPASS blog. He has presented at major scientific conferences, including a seminar lecture at the annual Drosophila Research Conference. Dr Bernardo is also a freelance writer for the Department of Communication and Public Affairs at Albert Einstein College of Medicine, and is author of the science communication and policy blog, Liber et Scientia.

    Medical Writing Experience

    As a Medical Writer, Dr Bernardo provides pharmaceutical companies with medical writing and editing services for promotional brochures, thought-leader advisory boards, discussion roundtables, continuing medical education slide decks, and web site content. He is the lead content developer for branded and unbranded campaigns supporting therapeutics in both pre-launch and post-marketing phases of development, with experience in diverse disease states including Crohn’s disease, hemophilia, iron deficiency anemia, ischemic stroke, multiple sclerosis, and ulcerative colitis.

    Editing Experience

    Dr Bernardo joined Edanz Group as an editor in 2017.